Kura Oncology
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Kura Oncology generated cash of -$124,824,000, which is less than the previous year. Cash used in financing activities reached the amount of $94,783,000 last year. Net change in cash is therefore -$14,484,000.
Cash Flow
| 2014 | -849K | -28K | 2.00M |
|---|---|---|---|
| 2015 | -17.92M | -70.62M | 102.87M |
| 2016 | -25.34M | 12.17M | 7.45M |
| 2017 | -28.44M | -23.41M | 53.56M |
| 2018 | -48.65M | -79.3M | 132.64M |
| 2019 | -54.76M | -46.32M | 111.10M |
| 2020 | -69.83M | -99.93M | 469.33M |
| 2021 | -104.55M | -126.83M | -3.43M |
| 2022 | -110.06M | 32.62M | 38.56M |
| 2023 | -124.82M | 15.55M | 94.78M |
KURA Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 51.80M | 90.88M | 325.70M | 26.13M | 16.11M | 11.43M | 9.72M | 15.44M | 1.12M | 6.56K |
Operating activities | ||||||||||
Net income | -152.63M | -135.84M | -130.46M | -89.62M | -63.14M | -60.44M | -35.43M | -27.56M | -22.62M | -3.67M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 849K | 759K | 558K | 194K | 0 | 10K | 30K | 31K | 20K | 1K |
Stock-based compensation expense | 28.08M | 26.31M | 23.57M | 12.80M | 9.40M | 0 | 4.54M | 2.08M | 2.25M | 0 |
| Deferred income tax benefit | 28.08M | 26.31M | 23.57M | 12.80M | 9.40M | 0 | 4.54M | 2.08M | 2.25M | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 210K | -8K | 79K | 135K | -400K | 0 |
Inventories | 0 | 0 | 0 | 0 | -856K | -443K | -750K | -199K | 153K | 0 |
Accounts payable | 0 | -802K | -2.51M | 5.67M | 856K | 5.10M | 3.60M | 471K | 2.81M | -1.5K |
Cash generated by operating activities | -124.82M | -110.06M | -104.55M | -69.83M | -54.76M | -48.65M | -28.44M | -25.34M | -17.92M | -849K |
Investing activities | ||||||||||
Purchases Of Investments | -409.82M | -270.65M | -445.65M | -320.96M | -227.57M | -237.44M | -100.63M | -56.42M | -76.56M | 0 |
Investments In Property Plant And Equipment | -168K | -626K | -1.14M | -2.17M | 0 | 0 | 0 | 0 | -64K | 0 |
Acquisitions Net | 0 | -33.25K | 125.68K | 97.76K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 15.55M | 32.62M | -126.83M | -99.93M | -46.32M | -79.3M | -23.41M | 12.17M | -70.62M | -28K |
Financing activities | ||||||||||
Common Stock Issued | 93.57M | 24.72M | 4.42M | 459.33M | 108.16M | 132.17M | 53.67M | 0 | 97.87M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K |
Repayments of term debt | 0 | 10M | -7.25M | -250K | 0 | -1.25M | 0 | 0 | 5M | 0 |
Cash used in financing activities | 94.78M | 38.56M | -3.43M | 469.33M | 111.10M | 132.64M | 53.56M | 7.45M | 102.87M | 2.00M |
Net Change In Cash | -14.48M | -38.87M | -234.82M | 299.56M | 10.01M | 4.68M | 1.70M | -5.71M | 14.31M | 1.11M |
Cash at end of period | 37.31M | 52.01M | 90.88M | 325.70M | 26.13M | 16.11M | 11.43M | 9.72M | 15.44M | 1.12M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |